(A) Titration curve showing decreasing fluorescence intensities of lysozyme due to increasing concentration of mS100A6. (B) The nonlinear line of relative intensities against the total concentrations of mS100A6. (C) Titration curve of lysozyme decreasing fluorescence intensities against increasing tranilast concentration. (D) The nonlinear line of relative intensity against the total concentrations of tranilast.</p
We investigated the anti-proliferative effects of recombinant human lysozyme (rHlys) on gastric canc...
(A) The structure of S100A1-RAGE V domain complex (yellow and green respectively). (B) S100A4 (in re...
<p>A) Molecular interaction between S100A4 and RAGE by SPR. Overlayed sensorgrams of interaction bet...
(A) Overlapped HSQC spectra of 15N-labeled lysozyme (red) and of 15N-labeled lysozyme with unlabeled...
(A) Overlapped HSQC spectra of 15N-labeled lysozyme (red) and of 15N-labeled lysozyme with mS100A6 (...
(A) Structure of mS100A6-RAGE V domain complex [26]. (B) The lysozyme-mS100A6-RAGE V domain complex....
(A) Overlapped HSQC spectra of 15N-labeled mS100A6 (red) and of 15N-labeled mS100A6 with unlabeled l...
In this report, using NMR and molecular modeling, we have studied the structure of lysozyme-S100A6 c...
(A) Structural formula of tranilast. (B) 3D structure of tranilast. (C) Model of the lysozyme-tranil...
In this report, using NMR and molecular modeling, we have studied the structure of lysozyme-S100A6 c...
<p>(A). Emission spectra of 2 μM S100A9 fluorescence titrations exhibiting decreased fluorescence in...
(A) Superimposed HSQC of the 15N S100A4 complex with unlabeled S100A1 (red) and free 15N S100A4 (bla...
<p>A. <i>M</i>. <i>luteus</i> was exposed to vehicle control, 2 μg/mL human lysozyme alone, or 2 μg/...
(A) Overlapping 15N S100A1 HSQC spectra (black) and the 15N S100A1 complex with unlabeled S100A4 (re...
<p>To maintain clarity, only the representative curves of control unmodified protein (solid lines) a...
We investigated the anti-proliferative effects of recombinant human lysozyme (rHlys) on gastric canc...
(A) The structure of S100A1-RAGE V domain complex (yellow and green respectively). (B) S100A4 (in re...
<p>A) Molecular interaction between S100A4 and RAGE by SPR. Overlayed sensorgrams of interaction bet...
(A) Overlapped HSQC spectra of 15N-labeled lysozyme (red) and of 15N-labeled lysozyme with unlabeled...
(A) Overlapped HSQC spectra of 15N-labeled lysozyme (red) and of 15N-labeled lysozyme with mS100A6 (...
(A) Structure of mS100A6-RAGE V domain complex [26]. (B) The lysozyme-mS100A6-RAGE V domain complex....
(A) Overlapped HSQC spectra of 15N-labeled mS100A6 (red) and of 15N-labeled mS100A6 with unlabeled l...
In this report, using NMR and molecular modeling, we have studied the structure of lysozyme-S100A6 c...
(A) Structural formula of tranilast. (B) 3D structure of tranilast. (C) Model of the lysozyme-tranil...
In this report, using NMR and molecular modeling, we have studied the structure of lysozyme-S100A6 c...
<p>(A). Emission spectra of 2 μM S100A9 fluorescence titrations exhibiting decreased fluorescence in...
(A) Superimposed HSQC of the 15N S100A4 complex with unlabeled S100A1 (red) and free 15N S100A4 (bla...
<p>A. <i>M</i>. <i>luteus</i> was exposed to vehicle control, 2 μg/mL human lysozyme alone, or 2 μg/...
(A) Overlapping 15N S100A1 HSQC spectra (black) and the 15N S100A1 complex with unlabeled S100A4 (re...
<p>To maintain clarity, only the representative curves of control unmodified protein (solid lines) a...
We investigated the anti-proliferative effects of recombinant human lysozyme (rHlys) on gastric canc...
(A) The structure of S100A1-RAGE V domain complex (yellow and green respectively). (B) S100A4 (in re...
<p>A) Molecular interaction between S100A4 and RAGE by SPR. Overlayed sensorgrams of interaction bet...